Halozyme Therapeutics, Inc.

FIFTH THIRD BANCORP HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

1,582

Value ($000)

106

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	106	0.0%	1,582	12/31/2025
2025 Q3	11/7/2025	110	0.0%	1,498	9/30/2025
2025 Q2	7/15/2025	304	0.0%	5,852	6/30/2025
2025 Q1	4/15/2025	639	0.0%	10,017	3/31/2025
2024 Q4	1/21/2025	370	0.0%	7,741	12/31/2024
2024 Q3	10/17/2024	446	0.0%	7,799	9/30/2024
2024 Q2	7/22/2024	587	0.0%	11,206	6/30/2024
2024 Q1	4/23/2024	445	0.0%	10,945	3/31/2024
2023 Q4	1/19/2024	405	0.0%	10,970	12/31/2023
2023 Q3	10/31/2023	468	0.0%	12,262	9/30/2023
2023 Q2	7/26/2023	431	0.0%	11,954	6/30/2023
2023 Q1	4/24/2023	388	0.0%	10,159	3/31/2023
2022 Q4	1/25/2023	733	0.0%	12,885	12/31/2022
2022 Q3	10/25/2022	555	0.0%	14,035	9/30/2022
2022 Q2	8/4/2022	618	0.0%	14,044	6/30/2022
2022 Q1	4/19/2022	562	0.0%	14,092	3/31/2022
2021 Q4	2/1/2022	474	0.0%	11,793	12/31/2021
2021 Q3	10/15/2021	458	0.0%	11,259	9/30/2021
2021 Q2	8/6/2021	492	0.0%	10,842	6/30/2021
2021 Q1	5/7/2021	434	0.0%	10,412	3/31/2021
2020 Q4	2/16/2021	421	0.0%	9,854	12/31/2020
2020 Q3	11/9/2020	146	0.0%	5,556	9/30/2020
2020 Q2	8/5/2020	4	0.0%	135	6/30/2020
2020 Q1	5/5/2020	2	0.0%	135	3/31/2020
2019 Q4	2/14/2020	2	0.0%	135	12/31/2019